Notes from the Field: Increases in Imported Malaria Cases - Three Southern U.S. Border Jurisdictions, 2023.
| Autor: | Mitchell CL, Kennar A, Vasquez Y, Noris K, Williamson T, Mannell A, Taylor A, Ruberto I, Cullen TA, Singletary M, Shah S, Ocaranza H, Rodriguez Lainz A, Mace KE |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 May 09; Vol. 73 (18), pp. 417-419. Date of Electronic Publication: 2024 May 09. |
| DOI: | 10.15585/mmwr.mm7318a2 |
| Abstrakt: | Malaria is a severe and potentially fatal mosquitoborne disease caused by infection with Plasmodium spp. parasites. Although malaria is no longer endemic in the United States, imported infections are reported annually; the primary risk group has been U.S. residents traveling to areas where malaria is endemic (1). In 2023, sporadic locally acquired mosquito-transmitted malaria cases were reported in several U.S. states (2,3). This report describes increases in imported malaria cases in 2023 compared with 2022 in three public health jurisdictions along the U.S. southern border. Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|